These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 17850927

  • 1. The PPAR-alpha gene in Alzheimer's disease: lack of replication of earlier association.
    Sjölander A, Minthon L, Bogdanovic N, Wallin A, Zetterberg H, Blennow K.
    Neurobiol Aging; 2009 Apr; 30(4):666-8. PubMed ID: 17850927
    [Abstract] [Full Text] [Related]

  • 2. Interaction between the APOE epsilon4 allele and the APH-1b c + 651T > G SNP in Alzheimer's disease.
    Poli M, Gatta LB, Lovati C, Mariani C, Galimberti D, Scarpini E, Biunno I, Musicco M, Dominici R, Albertini A, Finazzi D.
    Neurobiol Aging; 2008 Oct; 29(10):1494-501. PubMed ID: 17466415
    [Abstract] [Full Text] [Related]

  • 3. Lack of association between TNF-alpha polymorphisms and Alzheimer's disease in an Italian cohort.
    Tedde A, Putignano AL, Nacmias B, Bagnoli S, Cellini E, Sorbi S.
    Neurosci Lett; 2008 Dec 03; 446(2-3):139-42. PubMed ID: 18834925
    [Abstract] [Full Text] [Related]

  • 4. TAU haplotype and the Saitohin Q7R gene polymorphism do not influence CSF Tau in Alzheimer's disease and are not associated with frontotemporal dementia or Parkinson's disease.
    Johansson A, Zetterberg H, Håkansson A, Nissbrandt H, Blennow K.
    Neurodegener Dis; 2005 Dec 03; 2(1):28-35. PubMed ID: 16909000
    [Abstract] [Full Text] [Related]

  • 5. Influence of the Pro12Ala polymorphism of PPAR-gamma on age at onset and sRAGE levels in Alzheimer's disease.
    Yao L, Li K, Zhang L, Yao S, Piao Z, Song L.
    Brain Res; 2009 Sep 29; 1291():133-9. PubMed ID: 19631630
    [Abstract] [Full Text] [Related]

  • 6. Lack of genetic association between PPARG gene polymorphisms and Finnish late-onset Alzheimer's disease.
    Helisalmi S, Tarvainen T, Vepsäläinen S, Koivisto AM, Hiltunen M, Soininen H.
    Neurosci Lett; 2008 Aug 22; 441(2):233-6. PubMed ID: 18573313
    [Abstract] [Full Text] [Related]

  • 7. A GSTM3 polymorphism associated with an etiopathogenetic mechanism in Alzheimer disease.
    Maes OC, Schipper HM, Chong G, Chertkow HM, Wang E.
    Neurobiol Aging; 2010 Jan 22; 31(1):34-45. PubMed ID: 18423940
    [Abstract] [Full Text] [Related]

  • 8. TNFR-associated factor-2 (TRAF-2) in Alzheimer's disease.
    Culpan D, Cram D, Chalmers K, Cornish A, Palmer L, Palmer J, Hughes A, Passmore P, Craig D, Wilcock GK, Kehoe PG, Love S.
    Neurobiol Aging; 2009 Jul 22; 30(7):1052-60. PubMed ID: 18069092
    [Abstract] [Full Text] [Related]

  • 9. Serum levels and genetic variation of TGF-beta1 are not associated with Alzheimer's disease.
    Rodríguez-Rodríguez E, Sánchez-Juan P, Mateo I, Llorca J, Infante J, García-Gorostiaga I, Berciano J, Combarros O.
    Acta Neurol Scand; 2007 Dec 22; 116(6):409-12. PubMed ID: 17986101
    [Abstract] [Full Text] [Related]

  • 10. Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimer's disease.
    Arosio B, Trabattoni D, Galimberti L, Bucciarelli P, Fasano F, Calabresi C, Cazzullo CL, Vergani C, Annoni G, Clerici M.
    Neurobiol Aging; 2004 Sep 22; 25(8):1009-15. PubMed ID: 15212825
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Lack of association between Interleukin-18 gene promoter polymorphisms and onset of Alzheimer's disease.
    Segat L, Milanese M, Arosio B, Vergani C, Crovella S.
    Neurobiol Aging; 2010 Jan 22; 31(1):162-4. PubMed ID: 18433937
    [Abstract] [Full Text] [Related]

  • 14. Relationship of the Ubiquilin 1 gene with Alzheimer's and Parkinson's disease and cognitive function.
    Arias-Vásquez A, de Lau L, Pardo L, Liu F, Feng BJ, Bertoli-Avella A, Isaacs A, Aulchenko Y, Hofman A, Oostra B, Breteler M, van Duijn C.
    Neurosci Lett; 2007 Aug 31; 424(1):1-5. PubMed ID: 17709205
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Study on the association between SOAT1 polymorphisms, Alzheimer's disease risk and the level of CSF biomarkers.
    Lamsa R, Helisalmi S, Herukka SK, Tapiola T, Pirttila T, Vepsalainen S, Hiltunen M, Soininen H.
    Dement Geriatr Cogn Disord; 2007 Aug 31; 24(2):146-50. PubMed ID: 17622762
    [Abstract] [Full Text] [Related]

  • 17. Genetic variation in CTNNA3 encoding alpha-3 catenin and Alzheimer's disease.
    Blomqvist ME, Andreasen N, Bogdanovic N, Blennow K, Brookes AJ, Prince JA.
    Neurosci Lett; 2004 Apr 01; 358(3):220-2. PubMed ID: 15039120
    [Abstract] [Full Text] [Related]

  • 18. Polymorphisms at the beta2-adrenergic receptor gene influence Alzheimer's disease susceptibility.
    Yu JT, Tan L, Ou JR, Zhu JX, Liu K, Song JH, Sun YP.
    Brain Res; 2008 May 19; 1210():216-22. PubMed ID: 18423577
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.